A key part of Public Health Sciences research is the population at large — we can’t overstate the importance of volunteers to our research. We use the cancer registry to learn about the incidence of cancer, work with regional organizations to increase fruit and vegetable intake, and bring participants in for exercise or nutrition studies.
We focus on prevention strategies that directly impact the population. Our scientists explore the link between hormone replacement therapy and breast cancer, find new ways of reaching communities to increase cancer screening and other healthy behaviors, offer mobile apps to help people quit smoking, and bring the issue of health disparities to the forefront of research.
Public Health Sciences research is conducted through partnerships across five programs: Biostatistics, Cancer Prevention, Computational Biology, Epidemiology, and Translational Research.
The Fred Hutch Biostatistics Program is known internationally for strong methodologic contributions and collaborative work. We provide statistical support for research programs at the Hutch, as well as the organizations we partner with.
Our scientists develop and evaluate new quantitative methods to design and analyze a broad range of biomedical studies. We also construct biomathematical models of carcinogenesis and other biological processes.
Through collaborative efforts, we’ve developed some of the most impactful statistics methods, including the standards for study designs used in biomarker research, methods to accommodate measurement error in nutrition studies, and several advancements for genome-wide association and sequencing studies.
Cancer Prevention is a diverse program in Public Health Sciences, with expertise in epidemiology, biostatistics, nutrition, physical activity, genomics, behavioral science, health economics, health disparities, health communications, primary care and oncology. We evaluate the causes, detection and control of cancer in laboratory, clinic and community-based studies.
The OCOE is a partnership between Fred Hutch, UW, Seattle Children's Hospital, and SCCA. We research health disparities among communities, with the goal of reducing overall mortality rates.
GMaP is a research and training network designed to foster collaboration among cancer health disparities researchers, trainees, outreach workers, and organizations.
We’ve partnered with NMSU to recruit scientists from underrepresented communities into cancer research to expand our knowledge of and address issues with cancer health disparities.
The WHI is a major, long-term research program designed to address cardiovascular disease, cancer and osteoporosis — the most frequent causes of death, disability and poor quality of life in postmenopausal women.
Our program addresses biological questions with computational methods and tools. Using a wide range of bioinformatic and computational approaches, we can identify and explore new areas of research in biotechnologies, especially those based on genome-scale and other molecular tests.
In Epidemiology, we explore cancer risk factors based on lifestyle, environment, genetics, biomarkers and infectious agents. Our studies include personal exposures, behavioral characteristics, and genes that may influence a person’s chances of developing breast, prostate, esophageal, and HPV-related cancers.
We’re a global breast cancer community united to make breast health a priority and reduce disparities in breast cancer outcomes worldwide.
The BHGI develops evidence-based, economically feasible, and culturally appropriate guidelines for low- and middle-income countries. We aim to improve access to breast cancer screening, detection and treatment.
The CERC is a research unit of epidemiologists, support staff, statisticians, IT, interviewers, and data technicians. We study the causes, prevention and survival factors of cancer, as well as how it affects quality of life.
We provide high quality data on the incidence, treatment, and follow-up on newly-diagnosed cancers occurring in 13 Washington State counties.
We conduct molecular and epidemiological research, then translate our findings for broad application from bench to bedside. In the lab, we advance our understanding of the biological basis for various exposure/disease relationships. In the clinic, our research informs risk assessment, early disease detection, prognostication, treatment decision making and survivorship.